Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Tuesday broker round-up UPDATE

Tue, 09th Jul 2013 07:53
Adept Telecom: Northland Capital revises target price from 108p to 115p and maintains a buy recommendation.AG Barr: Panmure Gordon raises target price from 500p to 600p and retains a hold recommendation.Aquarius Platinum: Westhouse Securities shifts target price from 35p to 40p upgrading from sell to neutral.Ashmore Group: UBS reduces target price from 400p to 365p, while leaving its neutral rating unaltered.Aveva: Panmure Gordon increases target 0price from 2091p to 2174p, while its hold recommendation is kept.Bovis Homes Group: Deutsche Bank moves target price from 878p to 900p retaining a buy recommendation.British American Tabacco: Canaccord Genuity reduces target price from 3225p to 3000p and downgrades from hold to sell.Britvic: Panmure Gordon downgrades from buy to hold with a target price of 521p.Centamin: Canaccord Genuity lowers target price from 55p to 50p, while its buy recommendation is kept. Fox Davies shifts target price from 41p to 36p and leaves its hold recommendation unchanged.Cineworld: Investec ups target price from 360p to 380p and maintains a buy recommendation.Consort Medical: Canaccord Genuity moves target price from 855p to 895p retaining a buy recommendation.Experian: Deutsche Bank takes target price from 1200p to 1300p and stays with its buy recommendation.G4S: Investec cuts target price from 320p to 280p, while reiterating its buy recommendation.Halfords Group: HSBC Holdings cuts target price from 365p to 340p and maintains a buy recommendation.Hochschild Mining: Fox Davies lowers target price from 290p to 224p, while upgrading to buy.Imperial Tabacco: Canaccord Genuity reduces target price from 2900p to 2450p downgrading from buy to hold.Innovation Group: N+1 Singer shifts target price from 29p to 34p and leaves its buy recommendation unchanged.ITE Group: Investec moves target price from 325p to 335p keeping a buy recommendation.Jupiter Fund Management: Canaccord Genuity increases target price from 355p to 370p and maintains a buy recommendation.Lloyds Banking Group: Investec takes target price from 50p to 65p, but still recommends selling.Lonmin: Westhouse Securities ups target price from 250p to 265p and upgrades from sell to neutral.Pearson: Investec raises target price from 1150p to 1250p and upgrades from hold to add.Playtech: Morgan Stanley initiates with a target price of 800p and an overweight rating.Reed Elsevier: Nomura ups target price from 810p to 860p keeping a buy recommendation. Investec moves target price from 800p to 850p and retains its buy recommendation.Rolls-Royce Group: UBS takes target price from 850p to 900p, but still recommends selling.Royal Bank of Scotland: Investec moves target price from 310p to 320p and reiterates a buy recommendation.Sagentia Group: Westhouse Securities revises target price from 125p to 145p and upgrades from neutral to add.SIG: Panmure Gordon revises target price from 175p to 195p keeping its buy recommendation.Smiths News: N+1 Singer upgrades to buy with a target price of 185p.Supergroup: Panmure Gordon ups target price from 836p to 898p retaining a buy recommendation.Tarsus Group: Investec shifts target price from 250p to 260p staying with its buy recommendation.Ted Baker: Jefferies raises target price from 1700p to 2150p and maintains its buy recommendation.Topps Tiles: Goldman Sachs increases target price from 80p to 115p and moves from a buy to a strong buy recommendation.Travis Perkins: Panmure Gordon takes target price from 1350p to 1540p, while its hold recommendation id reiterated.Tullow Oil: UBS ups target price from 1120p to 1150p and retains its neutral rating.UBM: Investec reduces target price from 745p to 690p maintaining a hold recommendation.Weir Group: Jefferies raises target price from 1830p to 2150p and upgrades to equal-weight. Morgan Stanley ups to equal-weight from underweight.WPP: Investec increases target price from 1175p to 1250p and keeps a buy recommendation.XP Power: Investec moves target price from 1330p to 1375p and maintains a buy recommendation.

Related News

LONDON MARKET MIDDAY: Inflation steadies, easing pressure for BoE hike
2 hours ago

LONDON MARKET MIDDAY: Inflation steadies, easing pressure for BoE hike

(Alliance News) - Stock prices in London were little changed at midday on Wednesday, with investors digesting easing oil prices and steady UK inflatio...

WINNERS & LOSERS: Hays refocuses on core markets; Weir wins contract
4 hours ago

WINNERS & LOSERS: Hays refocuses on core markets; Weir wins contract

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.

IN BRIEF: Experian issues USD1 billion in 10-year bonds at 5.35%
5 hours ago

IN BRIEF: Experian issues USD1 billion in 10-year bonds at 5.35%

Experian PLC - Dublin-based provider of consumer credit score checking, fraud detection and credit application processing services - Prices an issue o...

CSRT.L News

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Monday broker round-up
10 Feb 2020

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm To Make No Further Changes To Consort Medical Offer
29 Jan 2020

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm Extends Consort Medical Offer Deadline To February 4
24 Jan 2020

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Buys 10% Of Takeover Target Consort Medical
22 Jan 2020

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
14 Jan 2020

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Friday broker round-up
10 Jan 2020

Friday broker round-up

(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.